These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4427222)
41. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment. Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625 [TBL] [Abstract][Full Text] [Related]
42. [Supplements to the editorial, "Liver protection therapy"]. Preisig R Schweiz Rundsch Med Prax; 1970 Nov; 59(45):1559-60. PubMed ID: 5478764 [No Abstract] [Full Text] [Related]
43. Relative efficacy. Stetler CJ J Med Assoc Ga; 1972 Sep; 61(9):312-5. PubMed ID: 5080001 [No Abstract] [Full Text] [Related]
44. Editorial: The pharmacist and drug product selection. Tice LF Am J Pharm Sci Support Public Health; 1974; 146(3):67-9. PubMed ID: 4851580 [No Abstract] [Full Text] [Related]
45. Use of drugs for unapproved indications: your legal responsibility. Eye Ear Nose Throat Mon; 1972 Dec; 51(12):493-5. PubMed ID: 4637969 [No Abstract] [Full Text] [Related]
46. A step closer to reality: professional flexible labeling for animal drugs. Gloyd JS J Am Vet Med Assoc; 1996 Feb; 208(4):457-9. PubMed ID: 8603883 [No Abstract] [Full Text] [Related]
47. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526 [TBL] [Abstract][Full Text] [Related]
48. Labeling and record keeping for compounded drugs. Ballitch EJ J Am Vet Med Assoc; 1994 Jul; 205(2):249-50. PubMed ID: 7928591 [No Abstract] [Full Text] [Related]
49. Responsible extra-label use of drugs. Cobb DV J Am Vet Med Assoc; 1996 Nov; 209(9):1545. PubMed ID: 8899012 [No Abstract] [Full Text] [Related]
54. Remarks by the Commissioner of Food and Drugs. Kessler DA Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001 [No Abstract] [Full Text] [Related]
55. Use of approved drugs for unlabeled indications. FDA Drug Bull; 1982 Apr; 12(1):4-5. PubMed ID: 7075926 [No Abstract] [Full Text] [Related]
56. Black box warnings in prescription drug labeling: results of a survey of 206 drugs. Beach JE; Faich GA; Bormel FG; Sasinowski FJ Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718 [No Abstract] [Full Text] [Related]
57. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule. Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711 [TBL] [Abstract][Full Text] [Related]
58. New classification of drugs. J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956 [No Abstract] [Full Text] [Related]
59. Regulatory milieu in India. Sheth UK Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):704-9. PubMed ID: 1269212 [No Abstract] [Full Text] [Related]
60. [A first in the drug industry--the underpinnings of a pill]. Habel L Nurs Que; 1989; 9(2):11. PubMed ID: 2927776 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]